Breaking the mold: asciminib as a standard-of-care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting

Yllmaz R., EŞKAZAN A. E.

Future Oncology, vol.19, no.8, pp.545-547, 2023 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Editorial Material
  • Volume: 19 Issue: 8
  • Publication Date: 2023
  • Doi Number: 10.2217/fon-2023-0095
  • Journal Name: Future Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.545-547
  • Keywords: ASC4FIRST, asciminib, chronic myeloid leukemia, STAMP, TKI, tyrosine kinase inhibitor
  • Istanbul University Affiliated: Yes